Tina Susan Nova insider trades: Arena Pharmaceuticals (ARNA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Tina reports to the SEC
and 5 more companies
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 26, 2020 | ARNA | ↓ Sell | 17,300 | $67.94 | $1.2M | Direct | Aug 28, 2020 (2d) |
| Mar 7, 2019 | ARNA | ↓ Sell | 1,200 | $45.99 | $55K | Direct | Mar 8, 2019 (1d) |
| Apr 14, 2014 | ARNA | ↓ Sell | 35,000 | $6.22 | $218K | Direct | Apr 15, 2014 (1d) |
| Nov 10, 2010 | GXDX | ↓ Sell | 1,624 | $17.68 | $29K | Direct | Nov 12, 2010 (2d) |
| Apr 6, 2010 | GXDX | ↓ Sell | 20,900 | $36.45 | $762K | Direct | Apr 8, 2010 (2d) |
| Mar 3, 2010 | GXDX | ↓ Sell | 16,700 | $31.90 | $533K | Direct | Mar 5, 2010 (2d) |
| Feb 3, 2010 | GXDX | ↓ Sell | 16,700 | $31.13 | $520K | Direct | Feb 5, 2010 (2d) |
| Jan 6, 2010 | GXDX | ↓ Sell | 20,900 | $34.72 | $726K | Direct | Jan 8, 2010 (2d) |
| Sep 3, 2009 | GXDX | ↓ Sell | 12,519 | $30.03 | $376K | Direct | Sep 8, 2009 (5d) |
| Aug 5, 2009 | GXDX | ↓ Sell | 15,259 | $30.34 | $463K | Direct | Aug 7, 2009 (2d) |
| Jul 6, 2009 | GXDX | ↓ Sell | 9,259 | $27.50 | $255K | Direct | Jul 8, 2009 (2d) |
| Jun 3, 2009 | GXDX | ↓ Sell | 9,259 | $29.64 | $274K | Direct | Jun 5, 2009 (2d) |
| May 5, 2009 | GXDX | ↓ Sell | 9,259 | $28.37 | $263K | Direct | May 7, 2009 (2d) |
| Apr 3, 2009 | GXDX | ↓ Sell | 9,259 | $29.01 | $269K | Direct | Apr 7, 2009 (4d) |
| Mar 4, 2009 | GXDX | ↓ Sell | 9,259 | $27.83 | $258K | Direct | Mar 6, 2009 (2d) |
| Feb 4, 2009 | GXDX | ↓ Sell | 18,518 | $33.74 | $625K | Direct | Feb 5, 2009 (1d) |
| Jan 6, 2009 | GXDX | ↓ Sell | 18,518 | $31.63 | $586K | Direct | Jan 8, 2009 (2d) |
| Mar 5, 2008 | GXDX | ↓ Sell | 118,212 | $25.50 | $3.0M | Direct | Mar 6, 2008 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Tina Susan Nova's insider trades
Tina Susan Nova is a director at Arena Pharmaceuticals (ARNA). Since Mar 5, 2008, Tina has reported no open-market purchases and 18 sales worth $10.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (58 filings), option exercises (19 filings), shares withheld for taxes (11 filings), gifts (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ARNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.